Efficacy and Safety of Tirzepatide for Weight Management

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 440 participants.

Also called NCT06918405

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 440 participants (planned count) (from the registry)
Sponsor
Chittagong Medical College (from the registry)
Registry
  • NCT NCT06918405
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Bangladesh (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06918405. Allocation not applicable; no masking; primary purpose treatment. Start 2025-01-01 (actual); primary completion 2026-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Tirzepatide for Weight Management
Condition
Obesity and Obesity-related Medical Conditions
Intervention (Drug)
Tirzepatide
Lead sponsor
Chittagong Medical College (class: other)

Record details

Record id
cardio:ct-nct06918405
Content hash
f046c12af90c0ecc2600e831a5e487ee072a0d97b4e562ce8e5ccc14fd9e8071